X T L Biopharmaceuticals Ltd (NASDAQ:XTLB)

1.96
Delayed Data
As of Jun 15
 +0.06 / +3.16%
Today’s Change
1.55
Today|||52-Week Range
4.14
-14.31%
Year-to-Date
No recent news for X T L Biopharmaceuticals Ltd.

Today’s Trading

Previous close1.90
Today’s open1.98
Day’s range1.96 - 1.98
Volume2,400
Average volume (3 months)41,112
Market cap$9.4M
Data as of 3:00pm ET, 06/15/2018

Growth & Valuation

Earnings growth (last year)+77.69%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio6.5
Price/Sales--
Price/Book2.59

Competitors

 Today’s
change
Today’s
% change
ATOSAtossa Genetics Inc-0.03-1.20%
CYANCyanotech Corp0.000.00%
IBIOIbio Inc+0.05+4.27%
ISRIsoRay Inc+0.09+21.14%
Data as of 8:00pm ET, 06/15/2018

Financials

Last reporting dateMarch 16, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$0.00
Annual profit (last year)-$786.5K
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
Joshua Levine
Chief Financial Officer
David Kestenbaum
Corporate headquarters
Raanana, Hamerkaz

Forecasts